The brain is a complex and sensitive organ, protected from the outside world by a series of barriers. These barriers, like the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB), act like a fortress, letting only certain molecules in while keeping out potential threats—including therapeutic drugs. This can make it tough to deliver medicines directly to the brain. One clever workaround is using the nasal route, which can transport drugs from the nose to the brain. This approach has been gaining attention with various commercial products and clinical trials already underway. It's like using a secret pathway to deliver drugs directly to where they're needed most.

The BBB, formed by a tight seal of capillary endothelial cells, is particularly challenging to bypass. The BCSFB, located at the choroid plexus, is slightly more porous but still presents hurdles. Uneven blood vessel distribution in solid tumors adds another layer of complexity, as drugs may not reach all cancer cells evenly. Nasal drug delivery offers a promising solution by skipping these barriers and delivering drugs directly to the central nervous system.

Researchers have been exploring different methods to make this work effectively. Commercial products and clinical trials are testing these approaches to ensure they're safe and effective. The findings so far show that nasal drug delivery has real potential for targeted and specific medicine delivery to the brain.

Cracking the Code: How the Nose Can Deliver Medicine to the Brain

Actions